Fragile X syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 10: Line 10:
   OMIM          = 309550 |
   OMIM          = 309550 |
   MedlinePlus    = |
   MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
   MeshID        = D005600 |
   MeshID        = D005600 |
}}
}}
Line 27: Line 25:
== [[Fragile X syndrome causes|Causes]] ==
== [[Fragile X syndrome causes|Causes]] ==


== [[Fragile X syndrome differential diagnosis|Differential Diagnosis]] ==
== [[Fragile X syndrome differential diagnosis|Differentiating Fragile X syndrome from other Diseases]] ==


== [[Fragile X syndrome epidemiology and demographics|Epidemiology and Demographics]] ==
== [[Fragile X syndrome epidemiology and demographics|Epidemiology and Demographics]] ==
Line 39: Line 37:
== Diagnosis ==
== Diagnosis ==


[[Fragile X syndrome history and symptoms|History and Symptoms]] | [[Fragile X syndrome physical examination|Physical Examination]] | [[Fragile X syndrome laboratory findings|Laboratory tests]] | [[Fragile X syndrome other diagnostic studies|Alternative diagnostics]]
[[Fragile X syndrome history and symptoms|History and Symptoms]] | [[Fragile X syndrome physical examination|Physical Examination]] | [[Fragile X syndrome laboratory findings|Laboratory Findings]] | [[Fragile X syndrome other diagnostic studies|Other Diagnostic Studies]]


== Treatment ==
== Treatment ==


[[Fragile X syndrome medical therapy|Medical therapy]] | [[Fragile X syndrome primary prevention|Primary Prevention]] | [[Fragile X syndrome secondary prevention|Secondary Prevention]] | [[Fragile X syndrome cost-effectiveness of therapy|Cost Effectiveness of Therapy]] | [[Fragile X syndrome future or investigational therapies|Future or Investigational Therapies]]
[[Fragile X syndrome medical therapy|Medical Therapy]] | [[Fragile X syndrome primary prevention|Primary Prevention]] | [[Fragile X syndrome secondary prevention|Secondary Prevention]] | [[Fragile X syndrome cost-effectiveness of therapy|Cost Effectiveness of Therapy]] | [[Fragile X syndrome future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
 
[[Fragile X syndrome case study one|Case #1]]
 


==External links==
==External links==

Revision as of 16:36, 29 August 2012

For patient information click here

Fragile X syndrome
Location of FMR1 gene
ICD-10 Q99.2
ICD-9 759.83
OMIM 309550
DiseasesDB 4973
MeSH D005600

Fragile X syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fragile X syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fragile X syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fragile X syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fragile X syndrome

CDC on Fragile X syndrome

Fragile X syndrome in the news

Blogs on Fragile X syndrome

Directions to Hospitals Treating Fragile X syndrome

Risk calculators and risk factors for Fragile X syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fragile X syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


External links

Template:Pervasive developmental disorders Template:Chromosomal abnormalities

Categoyr:Disease state

Template:Link FA

Template:WH Template:WS